Literature DB >> 29645329

Modulating the Folding Landscape of Superoxide Dismutase 1 with Targeted Molecular Binders.

David N Bunck1, Beatriz Atsavapranee1, Anna K Museth1, David VanderVelde1, James R Heath1.   

Abstract

Amyotrophic lateral sclerosis, or Lou Gehrig's disease, is characterized by motor neuron death, with average survival times of two to five years. One cause of this disease is the misfolding of superoxide dismutase 1 (SOD1), a phenomenon influenced by point mutations spanning the protein. Herein, we used an epitope-specific high-throughput screen to identify a peptide ligand that stabilizes the SOD1 native conformation and accelerates its folding by a factor of 2.5. This strategy may be useful for fundamental studies of protein energy landscapes as well as designing new classes of therapeutics.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  high-throughput screening; neurodegenerative diseases; peptides; protein folding; superoxide dismutase 1

Mesh:

Substances:

Year:  2018        PMID: 29645329      PMCID: PMC6295353          DOI: 10.1002/anie.201802269

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  31 in total

1.  Dynamic properties of the G93A mutant of copper-zinc superoxide dismutase as detected by NMR spectroscopy: implications for the pathology of familial amyotrophic lateral sclerosis.

Authors:  Eric L Shipp; Francesca Cantini; Ivano Bertini; Joan Selverstone Valentine; Lucia Banci
Journal:  Biochemistry       Date:  2003-02-25       Impact factor: 3.162

2.  A General Synthetic Approach for Designing Epitope Targeted Macrocyclic Peptide Ligands.

Authors:  Samir Das; Arundhati Nag; JingXin Liang; David N Bunck; Aiko Umeda; Blake Farrow; Matthew B Coppock; Deborah A Sarkes; Amethist S Finch; Heather D Agnew; Suresh Pitram; Bert Lai; Mary Beth Yu; A Katrine Museth; Kaycie M Deyle; Bianca Lepe; Frances P Rodriguez-Rivera; Amy McCarthy; Belen Alvarez-Villalonga; Ann Chen; John Heath; Dimitra N Stratis-Cullum; James R Heath
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-17       Impact factor: 15.336

3.  Adverse effects of a SOD1-peptide immunotherapy on SOD1 G93A mouse slow model of amyotrophic lateral sclerosis.

Authors:  J Sábado; A Casanovas; H Rodrigo; G Arqué; J E Esquerda
Journal:  Neuroscience       Date:  2015-09-15       Impact factor: 3.590

4.  Common dynamical signatures of familial amyotrophic lateral sclerosis-associated structurally diverse Cu, Zn superoxide dismutase mutants.

Authors:  Sagar D Khare; Nikolay V Dokholyan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

Review 5.  Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.

Authors:  Sai V Seetharaman; Mercedes Prudencio; Celeste Karch; Stephen P Holloway; David R Borchelt; P John Hart
Journal:  Exp Biol Med (Maywood)       Date:  2009-07-13

6.  Solution structure of Apo Cu,Zn superoxide dismutase: role of metal ions in protein folding.

Authors:  Lucia Banci; Ivano Bertini; Fiorenza Cramaro; Rebecca Del Conte; Maria Silvia Viezzoli
Journal:  Biochemistry       Date:  2003-08-19       Impact factor: 3.162

7.  Chiral cyclohexane 1,3-diones as inhibitors of mutant SOD1-dependent protein aggregation for the treatment of ALS.

Authors:  Yinan Zhang; Radhia Benmohamed; Wei Zhang; Jinho Kim; Christina K Edgerly; Yaoqiu Zhu; Richard I Morimoto; Robert J Ferrante; Donald R Kirsch; Richard B Silverman
Journal:  ACS Med Chem Lett       Date:  2012-05-22       Impact factor: 4.345

8.  Structures of the G85R variant of SOD1 in familial amyotrophic lateral sclerosis.

Authors:  Xiaohang Cao; Svetlana V Antonyuk; Sai V Seetharaman; Lisa J Whitson; Alexander B Taylor; Stephen P Holloway; Richard W Strange; Peter A Doucette; Joan Selverstone Valentine; Ashutosh Tiwari; Lawrence J Hayward; Shelby Padua; Jeffrey A Cohlberg; S Samar Hasnain; P John Hart
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

Review 9.  The changing scene of amyotrophic lateral sclerosis.

Authors:  Wim Robberecht; Thomas Philips
Journal:  Nat Rev Neurosci       Date:  2013-03-06       Impact factor: 34.870

Review 10.  An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis.

Authors:  Melissa S Rotunno; Daryl A Bosco
Journal:  Front Cell Neurosci       Date:  2013-12-16       Impact factor: 5.505

View more
  3 in total

Review 1.  Protein-Catalyzed Capture Agents.

Authors:  Heather D Agnew; Matthew B Coppock; Matthew N Idso; Bert T Lai; JingXin Liang; Amy M McCarthy-Torrens; Carmen M Warren; James R Heath
Journal:  Chem Rev       Date:  2019-03-06       Impact factor: 60.622

Review 2.  Molecular and pharmacological chaperones for SOD1.

Authors:  Gareth S A Wright
Journal:  Biochem Soc Trans       Date:  2020-08-28       Impact factor: 5.407

3.  Antibody-recruiting protein-catalyzed capture agents to combat antibiotic-resistant bacteria.

Authors:  Matthew N Idso; Ajay Suresh Akhade; Mario L Arrieta-Ortiz; Bert T Lai; Vivek Srinivas; James P Hopkins; Ana Oliveira Gomes; Naeha Subramanian; Nitin Baliga; James R Heath
Journal:  Chem Sci       Date:  2020-02-12       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.